[The effect of thymogen on the heart in ischemia and reperfusion].
Filippova. O V OV; Reznikov. K M KM; Alabovskił. V V VV; Khamburov. V V VV; Vinokurov. A A AA
Key Findings
- Thymogen reduced heart damage in an ischemia‑reperfusion model.
- Its protective effect was stronger than that of dalargin and verapamil in the same test.
- The action does not involve opiate receptors or blocking calcium entry into heart cells.
Practical Outcomes
- The study suggests thymogen might have heart‑protective properties, but it’s only been shown in an isolated organ model, not in humans. No dosage, safety, or administration guidelines are provided, so it isn’t ready for self‑experimentation. Biohackers should view this as an early hint that warrants further research before considering any protocol.
Summary
In a lab test using isolated hearts, the peptide thymogen helped protect the heart from damage caused by cutting off and then restoring blood flow. It worked better than two other drugs (dalargin and verapamil) and did so without using the usual opioid or calcium‑channel pathways.
Abstract
The anti-ischemic properties of thymogen were studied on an isolated heart model. Its cardioprotective effect was higher than that of dalargin and verapamil. The mechanism of the thymogen anti-ischemic action is realized without the participation of the opiate receptors and blockade of calcium entrance into the cardiomyocytes.
Study Information
pubmed
1997